Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-024002
Filing Date
2024-06-17
Accepted
2024-06-14 20:59:06
Documents
6
Effectiveness Date
2024-06-17

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 97614
2 ex5-1.htm EX-5.1 14997
3 ex23-1.htm EX-23.1 3863
4 ex23-2.htm EX-23.2 3453
5 ex107.htm EX-FILING FEES 13223
6 ex5-1_001.jpg GRAPHIC 3807
  Complete submission text file 0001493152-24-024002.txt   139669
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280250 | Film No.: 241046789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)